INOVIO PHARMACEUTICALS, INC. Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
INOVIO PHARMACEUTICALS, INC. (INO) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of $30.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2013-03-18
- INOVIO PHARMACEUTICALS, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was $30.00K, a 11.11% increase from fiscal 2011.
- INOVIO PHARMACEUTICALS, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was $27.00K, a 61.97% decline from fiscal 2010.
- INOVIO PHARMACEUTICALS, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2010 was $71.00K.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | $30.00K 10-K · filed 2013-03-18 |
| 2011-12-31 | $27.00K 10-K · filed 2013-03-18 |
| 2010-12-31 | $71.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |